Clinical Trial Update: A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating ASP5502 in healthy adults and adults with primary Sjögren's syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• ASP5502

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Healthy Volunteers, Sjögren's Syndrome | Phase 1 | Status: TERMINATED